Technetium Tc-99m tilmanocept Completed Phase 4 Trials for Cancer, Breast Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic4
clinicaltrials.gov IdentifierTitleDrugs
NCT02287675Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer